Smith Dean G
Department of Health Management and Policy, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA.
Am J Manag Care. 2007 Jun;13 Suppl 3:S68-71.
A literature review was undertaken to describe trends in the prevalence of dyslipidemia and the associated medical costs. The search focused on recent trials showing effects of treatment on strokes and in patients with diabetes mellitus (DM). Online databases were searched for recent studies analyzing prevalence and/or cost of dyslipidemia, stroke, and DM. More than 43,000 papers have been written on dyslipidemia, with 700 considering costs and more than 100 focusing on the costs of dyslipidemia alongside stroke or DM. Findings in almost every case point toward high costs associated with dyslipidemia and cost-effective therapeutic options for treatment. The findings indicate that dyslipidemia is widespread and imposes substantial costs on the healthcare system. Treatment of elevated cholesterol and mixed lipid disorders using statins may relieve some of the burden, as recently noted for patients with DM and stroke.
进行了一项文献综述，以描述血脂异常患病率的趋势以及相关的医疗费用。搜索重点是近期显示治疗对中风和糖尿病（DM）患者有影响的试验。在在线数据库中搜索了近期分析血脂异常、中风和糖尿病患病率和/或费用的研究。关于血脂异常的论文已超过43,000篇，其中700篇考虑了费用，100多篇关注血脂异常与中风或糖尿病相关的费用。几乎在每种情况下的研究结果都表明血脂异常相关费用高昂以及有成本效益的治疗选择。研究结果表明血脂异常普遍存在，并给医疗保健系统带来巨大成本。使用他汀类药物治疗高胆固醇和混合性脂质紊乱可能会减轻一些负担，最近在糖尿病和中风患者中也有提及。
